Death is an integral part of life, as integral to our time on Earth as eating, breathing, finding shelter, searching for sufficient levels of sunlight, or birth itself. Unfortunately, a vast majority of deaths do not occur from old age. While heart disease takes the proverbial cake in leading causes of death here in the United States of America, cancer is just a hair’s width away from first place. Even worse, cancer is largely unpreventable in its entirety, although there are several screenings that detect cancer in its early stages or people genetically predisposed to it, with some treatments that work reasonably well and more information click here.
Without peer-reviewed, factual literature regarding human cancer and its study – referred to as oncology – physicians and researchers would have accomplished little at this point in time. That’s exactly why Oncotarget has reviewed, constructively criticized, edited, published, and distributed tons of individual articles and journal writings about cancer and oncology – to make leading literature available across the world to practitioners and researchers who can build upon existing lines of thought and learn more about Oncotarget.
Oncotarget, according to the scientific journal aggregator and collector SCImago Journal & Country Rank, is of higher quality than a whopping 85-plus percentage of journals about oncology in the entire English-speaking world, which is the largest reference to healthcare journals of all types, in this statistic, oncology and resume its.
While quality is, in many cases, conversely correlated to lower-quality materials, this couldn’t be further from the truth in regard to the publishing scholarly articles about the field of medicine, as practitioners and researchers alike put their reputation on the line if they’re not reviewed thoroughly enough. As such, Oncotarget is highly reputable thanks to the time its contributors put into reviewing works of research and Oncotarget’s lacrosse camp.
As a matter of fact, SCImago Journal & Country Rank is actually the most active in the world, having published just short of 300,000 scholarly works related to the treatment of cancer, an astounding 247,000 ahead of the journal in second place.
Oncotarget was created in 2010 by master scientific researchers Mikhail Blagosklonny and Andrei Gudskov of the Roswell Park Center Institute and is absolutely free for anyone to read or share and https://www.facebook.com/Oncotarget/.